<DOC>
	<DOCNO>NCT02735031</DOCNO>
	<brief_summary>Approximately 25 % patient type 1 diabetes lose capacity timely detect hypoglycaemia , condition refer impaired hypoglycaemic awareness ( IHA ) cause six-fold high risk severe , potentially hazardous , hypoglycaemia . IHA usually end-result process habituation recurrent hypoglycemia potentially reversible . Treatment glucagon-like peptide ( GLP ) -1 Receptor Agonists ( 1RAs ) addition insulin therapy may decrease incidence hypoglycaemia patient type 1 diabetes . This study test hypothesis treatment GLP-1RA , exenatide , add basal-bolus insulin therapy improve awareness hypoglycaemia patient type 1 diabetes IHA . In randomized doubleblind placebo-controlled cross-over trial , patient treat 6 week exenatide ( placebo ) , hypoglycemic symptom counterregulatory hormone response examine hyperinsulinemic hypoglycemic glucose clamp study .</brief_summary>
	<brief_title>Exenatide Impaired Hypoglycaemic Awareness Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Hypoglycemic Agents</mesh_term>
	<criteria>Type 1 diabetes , disease duration &gt; 1 year Age &gt; 18 year , &lt; 70 year Insulin treatment accord basalbolus insulin regimen ( injection insulin pump ) Impaired hypoglycaemic awareness assess score 3 modify Dutch translation Clarke questionnaire Glycated haemoglobin ( HbA1c ) ≥42 mmol/mol ( 6 % ) ≤75 mmol/mol ( 9.0 % ) Ability provide informed consent Treatment incretinbased therapy Known intolerance GLP1RAs ( include allergy ) Treatment glucosemodifying immunemodifying agent , e.g . prednisolon Recent history myocardial infarction stroke ( past year ) laser coagulation proliferative retinopathy ( past 6 month ) Proliferative retinopathy Symptomatic diabetic neuropathy Diabetic nephropathy reflect albumincreatinin ratio &gt; 30 mmol/mg estimate Glomerular Filtration Rate ( eGFR ) &lt; 60 ml/min/1.73 m2 Known heart failure History pancreatitis ( acute chronic ) pancreatic cancer Bodymass index &gt; 40 kg/m2 Use premixed insulin longacting insulin alone Total daily insulin dose requirement &lt; 20 unit unless pump treatment Pregnancy unwillingness undertake measure birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Glucagon-Like Peptide 1</keyword>
	<keyword>Impaired hypoglycemic awareness</keyword>
</DOC>